John Lambert

John Lambert

Executive Chairman

John contributes significant experience of leadership at a senior level within the vaccine industry.

John Lambert has a wealth of experience in the vaccine industry including as President of Chiron Vaccines ahead of its acquisition by Novartis. Prior to Chiron, John was President of Aventis Pasteur MSD, the joint vaccine business of Merck and Sanofi Pasteur in Europe. More recently John has held a number of non-executive positions, including at Acambis, subsequently acquired by Sanofi, and Novavax.  He was M&A advisor to Crucell.